Studies have shown that the expression of connective tissue growth factor (CTGF) correlates with the progression of amyloid neuritic plaque neuropathology (Zhao et al., 2005), and CTGF expression is increased near Aβ plaques in post-mortem AD brains (Ueberham et al., 2003). The gene discussed is CCN2; the disease is Alzheimer disease.